Filing Details
- Accession Number:
- 0001209191-19-044253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-02 16:24:26
- Reporting Period:
- 2019-07-31
- Accepted Time:
- 2019-08-02 16:24:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1124140 | Exact Sciences Corp | EXAS | Services-Commercial Physical & Biological Research (8731) | 204782291 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187406 | J Daniel Levangie | C/O Exact Sciences Corp. 441 Charmany Drive Madison WI 53719 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-31 | 19,168 | $3.43 | 31,626 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-07-31 | 7,667 | $3.43 | 39,293 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-07-31 | 15,772 | $8.52 | 55,065 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-07-31 | 2,828 | $114.83 | 52,237 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-31 | 9,284 | $115.65 | 42,953 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-31 | 2,300 | $116.47 | 40,653 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-31 | 9,572 | $117.72 | 31,081 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-31 | 9,626 | $118.73 | 21,455 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-31 | 8,897 | $119.63 | 12,558 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-31 | 100 | $120.24 | 12,458 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2019-07-31 | 19,168 | $0.00 | 19,168 | $3.43 |
Common Stock | Stock Option (right to buy) | Disposition | 2019-07-31 | 7,667 | $0.00 | 7,667 | $3.43 |
Common Stock | Stock Option (right to buy) | Disposition | 2019-07-31 | 15,772 | $0.00 | 15,772 | $8.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-07-16 | 2020-07-16 | No | 4 | M | Direct |
0 | 2011-07-16 | 2020-07-16 | No | 4 | M | Direct |
0 | 2012-07-28 | 2021-07-28 | No | 4 | M | Direct |
Footnotes
- Represents shares of common stock received upon exercise of a stock option award.
- The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 25, 2019, a portion of which were sold to cover certain tax liabilities arising out of the vesting of shares of restricted stock.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.09 to $115.08, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.115 to $116.10, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.13 to $116.96, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.18 to $118.18, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.20 to $119.18, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.23 to $120.23, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.